Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2

Xiumin Lu1, Nan Su, Jing Yang

  • 1State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.

Insights

Fibroblast growth factor receptor 1 (FGFR1) is essential for osteoclast differentiation and function. FGFR1 deficiency in mice impairs bone remodeling by reducing osteoclast number and activity.

Area of Science:

  • Bone Biology
  • Cell Signaling
  • Skeletal Physiology

Background:

  • Osteoclasts are critical for bone remodeling, and their dysfunction contributes to bone diseases.
  • Fibroblast growth factor receptor 1 (FGFR1) signaling pathways are implicated in various cellular processes, but its specific role in osteoclast biology requires further elucidation.

Purpose of the Study:

  • To investigate the direct role and underlying mechanisms of FGFR1 signaling in osteoclast differentiation and activation.
  • To determine the impact of FGFR1 deficiency on bone remodeling in vivo and osteoclast function in vitro.

Main Methods:

  • Conditional inactivation of FGFR1 in mouse bone marrow monocytes and mature osteoclasts.
  • In vitro differentiation assays to assess osteoclast formation and tartrate-resistant acid phosphatase (TRAP) positive osteoclast counts.
  • Bone resorption assays to evaluate the functional capacity of osteoclasts.
  • Gene expression analysis (TRAP, MMP-9) and Western blotting for Erk1/2 mitogen-activated protein (MAP) kinase phosphorylation.

Main Results:

  • Mice with FGFR1 deficiency (Fgfr1(-/-)) displayed dysregulated bone remodeling, characterized by a reduced number of osteoclasts and impaired osteoclast function.
  • In vitro studies showed significantly diminished TRAP-positive osteoclast formation from Fgfr1(-/-) bone marrow monocytes.
  • Bone resorption activity of mature osteoclasts from Fgfr1(-/-) mice was suppressed, with downregulated expression of key osteoclastic genes (TRAP, MMP-9) and decreased Erk1/2 MAP kinase phosphorylation.

Conclusions:

  • FGFR1 signaling is indispensable for the complete differentiation and activation of osteoclasts.
  • FGFR1 plays a crucial role in regulating osteoclast number, function, and the expression of genes vital for bone resorption.
  • Targeting FGFR1 signaling may offer therapeutic potential for bone diseases associated with osteoclast dysfunction.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...